ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion
Cardiovascular Diabetology, 06/14/2012Li H et al.
Treatment with the Rho/ROCK pathway inhibitor fasudil attenuated HG–induced monocyte–endothelial cell adhesion, possibly by reducing endothelial expression of VCAM–1 and MCP–1. These results suggest inhibition of Rho/ROCK signaling may have therapeutic potential in preventing diabetes associated vascular inflammation and atherogenesis.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.